Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Heim

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 13, 2022
Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous ForumMaxim E Shaydakov, Windsor Ting, Mikel Sadek, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Chest|March 31, 2012
Lung resection in hematologic patients with pulmonary invasive fungal diseaseChristian A Nebiker, Didier Lardinois, Lilian Junker, et al.
Blood|February 1, 2007
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phaseFrancois Guilhot, Jane Apperley, Dong-Wook Kim, et al.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Annals of Hematology|March 11, 2021
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohortMagdalena M Brune, Georg Stüssi, Pontus Lundberg, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Leukemia|February 27, 2018
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IVSusanne Saussele, Rüdiger Hehlmann, Alice Fabarius, et al.
Hematological Oncology|December 7, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 13, 2022
Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous ForumMaxim E Shaydakov, Windsor Ting, Mikel Sadek, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Chest|March 31, 2012
Lung resection in hematologic patients with pulmonary invasive fungal diseaseChristian A Nebiker, Didier Lardinois, Lilian Junker, et al.
Blood|February 1, 2007
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phaseFrancois Guilhot, Jane Apperley, Dong-Wook Kim, et al.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Annals of Hematology|March 11, 2021
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohortMagdalena M Brune, Georg Stüssi, Pontus Lundberg, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Leukemia|February 27, 2018
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IVSusanne Saussele, Rüdiger Hehlmann, Alice Fabarius, et al.
Hematological Oncology|December 7, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Pageof 12